Trulieve Cannabis Corp. · OTC:TCNNF

Trulieve Cannabis — Q3 2025 Earnings Presentation

18 slides from Trulieve Cannabis's earnings presentation, Nov 5, 2025

  1. Slide 1: Third Quarter 2025 Investor Presentation

    CSE: TRUL OTCQX: TCNNF Third Quarter 2025 Investor Presentation November 2025

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements Unless the context otherwise requires, the terms “Company,” “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. This presentation includes forward-looking information and statements within the meaning of the U.S. Pri

  3. Slide 3: Management's Use of Non-GAAP Financial Measures

    Management’s Use of Non-GAAP Financial Measures In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial measures, including adjusted SG&A, adjusted SG&A as % revenue, adjusted net income (loss), adjusted net income (loss) per diluted share, EB

  4. Slide 4: Agenda

    Agenda • Third Quarter 2025 Financial and Operational Highlights • Revenue Highlights • Recent Developments • Tax Position • 2025 Focus Areas • Financial Targets • Financial Highlights www.trulieve.com 4

  5. Slide 5: Third Quarter 2025 Financial and Operational Highlights

    Third Quarter 2025 Financial and Operational Highlights* • Revenue $288 million, with 94% of revenue from retail sales • GAAP gross profit of $170 million and 59% gross margin • Net loss attributable to common shareholders of $27 million • Adjusted net loss of $12 million excludes non-recurring char

  6. Slide 6: Revenue Highlights

    Revenue Highlights • Retail revenue $271 million • Traffic up 6% versus last year • Consistent with historical seasonal patterns • Sold over 12.5 million branded products • Up 7% year over year • Customer retention 68% companywide and 76% medical only • Exited quarter with 30% of retail locations ou

  7. Slide 7: Recent Developments

    Recent Developments • Announced planned redemption of $368 million of senior secured notes due 2026 • Launched new mobile app serving Florida customers enabling patients to browse and reserve products, view promotions, and check rewards status through a seamless digital experience • Currently operat

  8. Slide 8: Tax Position

    Tax Position • In Q4 2023, Trulieve filed amended federal tax returns for 2019, 2020, and 2021 claiming $143 million of refunds and corresponding amended state returns claiming $31 million of refunds • Amended returns were supported by legal interpretations that challenge the tax liability under Sec

  9. Slide 9: 2025 Focus Areas

    2025 Focus Areas Customer • Attract and Retain Customers • Deliver Exceptional Customer Experiences • Build and Reinforce Brand Loyalty Distribution • Expand Retail Network • Refresh, Remodel and Relocate Dispensaries As Needed • Strengthen and Expand Wholesale Partnerships Branded Products • Manage

  10. Slide 10: Financials

    Financials

  11. Slide 11: Financial Targets

    Financial Targets Financial Targets: • Anticipate fourth quarter revenue will be up low single-digits compared to the third quarter • 2025 cash flow from operations of at least $250 million expected • 2025 capital expenditures up to $45 million expected Financial Position as of September 30, 2025: •

  12. Slide 12: Financial Highlights

    Financial Highlights* INCOME STATEMENT HIGHLIGHTS (USD millions, except per share data) Q3:25 Q2:25 Q1:25 Q4.24 Q3:24 Q2:24 Q1:24 Q4:23 Q3:23 2024 2023 Revenue 288.2 302.1 297.8 301.1 284.3 303.4 297.6 287.0 275.2 1,186.5 1,129.2 Gross profit 169.9 182.9 183.2 187.0 173.3 181.6 173.8 153.9 142.9 715

  13. Slide 13: Financial Highlights

    Financial Highlights SHARE COUNT ESTIMATE (millions as of September 30, 2025 on as if converted basis) Subordinate Voting Shares 167.9 Multiple Voting Shares* 0.2 Total Shares Outstanding 191.1 *converted a t 100 s ubordi na te s ha res per 1 mul tipl e voting s ha re Employee Stock Options/RSUs 3.2

  14. Slide 14: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures EBITDA and Adjusted EBITDA For the Three Months Ended For the Nine Months Ended September 30, September 30, June 30, September 30, September 30, (Amounts expressed in millions of United States dollars; unaudited) 2025 2024 2025 2025 2024 Net loss attribu

  15. Slide 15: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures Adjusted Net (Loss) Income and Adjusted Net (Loss) Income Per Diluted Share For the Three Months Ended For the Nine Months Ended September 30, September 30, June 30, September 30, September 30, (Amounts expressed in millions of United States dollars; una

  16. Slide 16: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures Free Cash Flow and Adjusted SG&A For the Three Months Ended For the Nine Months Ended September 30, September 30, June 30, September 30, September 30, (Amounts expressed in millions of United States dollars; unaudited) 2025 2024 2025 2025 2024 Cash flow

  17. Slide 17: House of Brands

    House of Brands PREMIUM MID VALUE Trulieve Brands Partner Brands www.trulieve.com 17

  18. Slide 18: Thank You

    THANK YOU CSE: TRUL OTCQX: TCNNF @Trulieve/@Trulieve_IR ir@trulieve.com

Trulieve Cannabis — Q3 2025 Earnings Presentation on 6ix